Ardent Health Inc.
ARDT | NYSE
$10.61
+$0.13 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$10.61
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:05 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Revenue | 6.32B | 5.97B | 5.41B | 5.13B | 4.87B |
Cost of Revenue | 155.7M | 1.03B | 140.84M | 955.17M | 927.33M |
Gross Profit | 6.17B | 4.93B | 5.27B | 4.17B | 3.94B |
Operating Income | 325.58M | 405.76M | 229.5M | 217.03M | 436.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 286.36M | 363.06M | 151.61M | 311.48M | 295.89M |
Net Income | 135.81M | 210.34M | 50.29M | 188.91M | 154.26M |
Selling & General & Admin | 1.19B | 3.88B | 3.62B | 3.37B | 3.13B |
Research & Development | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 4.65B | 642.51M | 1.42B | 585.81M | 374.18M |
Operating Expenses | 5.84B | 4.53B | 5.04B | 3.96B | 3.51B |
Interest Expense | 55.2M | 65.58M | 65.43M | 82.05M | 93.83M |
Selling & Marketing Expenses | n/a | n/a | 14.87M | n/a | n/a |
Cost & Expenses | 6B | 5.56B | 5.18B | 4.91B | 4.43B |
Income Tax Expense | 56.22M | 63.35M | 22.64M | 46.11M | 51.31M |
Shares Outstanding (Basic) | 140.76M | 132.44M | 143.26M | 143.26M | 143.26M |
Shares Outstanding (Diluted) | 141.45M | 132.75M | 143.26M | 143.26M | 143.26M |
EPS (Basic) | 0.96 | 1.59 | 0.35 | 1.32 | 1.08 |
EPS (Diluted) | 0.96 | 1.58 | 0.35 | 1.32 | 1.08 |
EBITDA | 497.26M | 574.93M | 350M | 531.7M | 526.93M |
EBIT | 341.56M | 428.64M | 209.15M | 393.53M | 389.72M |
Depreciation & Amortization | 155.7M | 146.29M | 140.84M | 138.17M | 137.2M |
Add to Watchlist
Select watchlists to add or remove ARDT